WASHINGTON – The Consumer Healthcare Products Association (CHPA) today released the below statement following congressional passage of a $1.7 trillion government funding bill: “We applaud today’s passage of the Fiscal Year 2023 omnibus appropriations bill, which includes several CHPA-backed measures. CHPA is pleased that legislators prioritized measures that will advance consumer safety and protection, a critical
NEW YORK — Andrew Loucks, head of North American consumer healthcare at Sanofi, was elected to the Consumer Healthcare Products Association’s (CHPA) board of directors at its meeting here Thursday. Loucks has been in his current role at Sanofi since his appointment in August. “We very much look forward to Andrew’s participation on the CHPA
NEW YORK – The Consumer Healthcare Products Association (CHPA) Educational Foundation held its 7th Annual Gala last night at the Plaza Hotel in New York City. The widely attended event was a sweeping success, raising 45 percent more in donations compared to 2021, and bringing together 350 attendees from 82 companies across the self-care industry. The event
WASHINGTON – The Consumer Healthcare Products Association (CHPA) Educational Foundation announced on Monday an educational pilot launch to help consumers choose over-the-counter (OTC) pain relievers at the point of purchase. Featuring signage at nearly 19,000 Dollar General stores in 47 states, the campaign reflects the Foundation’s partnership with three CHPA member companies and Foundation supporters: Haleon, makers
WASHINGTON — Jay Sirois, CHPA’s vice president of regulatory & scientific affairs, and co-author of the paper,Considerations for determining safety of probiotics: A USP perspective, recently published in the Journal of Regulatory Toxicology and Pharmacology, released the following statement regarding the publication: “While safety assessments for many current probiotic species are backed by a solid history of safe
WASHINGTON – Consumer Healthcare Products Association (CHPA) president and CEO, Scott Melville, on Friday released the below statement following congressional passage of a short-term spending package to fund the Federal Government through Dec. 16. Included in this Continuing Resolution is legislation to reauthorize the U.S. Food and Drug Administration’s (FDA) user fee programs for prescription
BETHESDA, Md. – The Consumer Healthcare Products Association (CHPA) announced Tuesday its first-ever Regulatory & Scientific Affairs Career Achievement Award winners at its annual Regulatory, Scientific & Quality (RSQ) conference in Bethesda. Created to honor individuals maintaining a career of exceptional service and contributions withinthe consumer healthcare products industry, the establishment of this award and
WASHINGTON — Consumer Healthcare Products Association (CHPA) senior vice president of Dietary Supplements Duffy MacKay today released the following statement in response to results from a recent COSMOS-Mind study, published in Alzheimer & Dementia Journal, revealing statistically significant improvement on global cognition in participants who took a multivitamin over the course of the long-term clinical
WASHINGTON, DC) – Consumer Healthcare Products Association (CHPA) president and CEO, Scott Melville, today released the following statement in response to the U.S. Food and Drug Administration’s (FDA) announcement of a joint meeting between its Advisory Committees on Nonprescription Drugs and Obstetrics and Reproductive and Urologic Drugs. The meeting has been scheduled for Nov. 18,
WASHINGTON – The Consumer Healthcare Products Association (CHPA) Educational Foundation today released the following statement announcing the 2022 U.S. Self-Care Marketing Awards finalists. Winners will be announced at the Seventh Annual CHPA Educational Foundation Gala on November 16 at The Plaza Hotel in New York City. “Each year, we are increasingly impressed by the
WASHINGTON — The Consumer Healthcare Products Association (CHPA) released the following statement upon the U.S. Food and Drug Administration (FDA) final rule establishing a regulatory category for over-the-counter (OTC) hearing aids: “Consumer medical devices and other OTC products provide Americans with accessible, affordable, and trusted personal healthcare products, and now FDA has opened the door to
WASHINGTON – Consumer Healthcare Products Association (CHPA) president and CEO Scott Melville released the below statement Friday in response to a recent report published in the Journal of the American Medical Association (JAMA): “There can be no tolerance for illegal products masquerading as dietary supplements, especially after a manufacturer has already received an FDA warning letter.
WASHINGTON — CHPA’s president and CEO, Scott Melville, today released the following statement in response to news of HRA Pharma’s application to the U.S. Food and Drug Administration (FDA) for the first-ever over-the-counter (OTC) birth control pill in the United States: “CHPA is pleased to see the Rx-to-OTC switch pathway being used to broaden access to
WASHINGTON — CHPA’s senior vice president of Dietary Supplements, Duffy MacKay, ND, released the following statement in response to the U.S. Preventive Services Task Force (USPSTF) updated recommendation on vitamins, minerals, and multivitamin supplements: “The USPSTF found again what it found in 2014 and in 2021, that there is not yet enough evidence to determine
